PATENT CLAIM ANALYSIS

Application Number: 16007685
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "025000"]

Abstract:
The present invention relates to beta-glycolipid derivatives, their preparation and use as adjuvants in vaccines, as being suitable for being co-administered with antigens for vaccine prophylaxis and therapy. In certain embodiments, the beta-glycolipid derivatives of the invention also in their salified or complex form, are suitable for being co-administered with antigens for both therapeutic and prophylactic purposes or for vaccine prophylaxis and therapy.

Claim (Index 13):
The method of  claim 1 , wherein said beta-glycolipid derivative is 1,2-dipalmitoyl-3-[1\u2032\u03b2-(6-sulpho)-quinovosyl]-glycerol.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.68293
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15325640', '12440315', '12684685', '15866378', '14847835']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.642147114679431
- 35 USC 102 Novelty (BERT): 0.4972554341054996
- Combined Prediction Score: 0.6276579466220378
- Mean Citation Score: 204.801332
- Max Citation Score: 242.09113
- Similarity Product: 187.4216625050318

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test